Federal Register / Vol. 88, No. 225 / Friday, November 24, 2023 / Notices 82403 

Controlled substance Drug code Schedule 

Beta-hydroxyfentanyl .............................................................................................................................................................. 9830 I 

Beta-hydroxy-3-methylfentanyl ............................................................................................................................................... 9831 I 

3-Methylthiofentanyl ............................................................................................................................................................... 9833 I 

Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) .................................................................... 9834 I 

Thiofentanyl ............................................................................................................................................................................ 9835 I 

Beta-hydroxythiofentanyl ........................................................................................................................................................ 9836 I 

Ocfentanil ............................................................................................................................................................................... 9838 I 

beta′-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide; also known as b′-phenyl fentanyl; 3- 

phenylpropanoyl fentanyl).

9842 I 

N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide ................................................................................. 9843 I 

Crotonyl fentanyl ((E-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide) ........................................................................ 9844 I 

Cyclopropyl Fentanyl .............................................................................................................................................................. 9845 I 

ortho-Fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide; also known as 2-fluorobutyryl 

fentanyl).

9846 I 

Nabilone ................................................................................................................................................................................. 7379 II 

Alphaprodine .......................................................................................................................................................................... 9010 II 

Levomethorphan ..................................................................................................................................................................... 9210 II 

Racemethorphan .................................................................................................................................................................... 9732 II 

Alfentanil ................................................................................................................................................................................. 9737 II 

The company plans to import the 

listed controlled substances for 

distribution for analytical testing 

purposes. No other activities for these 

drug codes are authorized for this 

registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Claude Redd, 

Acting Deputy Assistant Administrator. 

[FR Doc. 2023-25989 Filed 11-22-23; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1297] 

Bulk Manufacturer of Controlled 

Substances Application: Sigma Aldrich 

Research Biochemicals, Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Sigma Aldrich Research 

Biochemicals, Inc. has applied to be 

registered as a bulk manufacturer of 

basic class(es) of controlled 

substance(s). Refer to SUPPLEMENTARY

INFORMATION listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before January 23, 2024. Such 

persons may also file a written request 

for a hearing on the application on or 

before January 23, 2024. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on October 27, 2023, 

Sigma Aldrich Research Biochemicals, 

Inc., 400–600 Summit Drive, Burlington, 

Massachusetts 01803, applied to be 

registered as a bulk manufacturer of the 

following basic class(es) of controlled 

substance(s): 

Controlled substance Drug 

code Schedule 

Lisdexamfetamine ......... 1205 I 

The company plans to manufacture 

the listed controlled substances as 

reference standards. No other activities 

for these drug codes are authorized for 

this registration. 

Claude Redd, 

Acting Deputy Assistant Administrator. 

[FR Doc. 2023–25992 Filed 11–22–23; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

[OMB Number 1121–0330] 

Agency Information Collection 

Activities; Proposed eCollection 

eComments Requested; Law 

Enforcement Congressional Badge of 

Bravery 

AGENCY: Office of Justice Programs, 

Department of Justice. 

ACTION: 30-Day notice. 

SUMMARY: The Office of Justice 

Programs, Bureau of Justice Assistance 

(BJA), Department of Justice (DOJ), will 

be submitting the following information 

collection request to the Office of 

Management and Budget (OMB) for 

review and approval in accordance with 

the Paperwork Reduction Act of 1995. 

The proposed information collection 

was previously published in the Federal 

Register on September 15, allowing a 

60-day comment period. 

DATES: Comments are encouraged and 

will be accepted for 30 days until 

December 26, 2023. 

FOR FURTHER INFORMATION CONTACT: If 

you have comments especially on the 

estimated public burden or associated 

response time, suggestions, or need a 

copy of the proposed information 

collection instrument with instructions 

or additional information, please 

contact: Gregory Joy at 202–514–1369, 

Policy Advisor, Bureau of Justice 

Assistance, 810 7th Street NW, 


ddrumheller on DSK120RN23PROD with NOTICES1
82404 Federal Register / Vol. 88, No. 225 / Friday, November 24, 2023 / Notices 

Washington, DC 20531; email: 

gregory.joy@usdoj.gov and telephone: 

(202) 514–1369. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Enhance the quality, utility, and 

clarity of the information to be 

collected; and/or 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Written comments and 

recommendations for this information 

collection should be submitted within 

30 days of the publication of this notice 

on the following website 

www.reginfo.gov/public/do/PRAMain. 

Find this particular information 

collection by selecting ‘‘Currently under 

30-day Review—Open for Public 

Comments’’ or by using the search 

function and entering either the title of 

the information collection or the OMB 

Control Number 1121–0330. This 

information collection request may be 

viewed at www.reginfo.gov. Follow the 

instructions to view Department of 

Justice, information collections 

currently under review by OMB. 

DOJ seeks PRA authorization for this 

information collection for three (3) 

years. OMB authorization for an ICR 

cannot be for more than three (3) years 

without renewal. The DOJ notes that 

information collection requirements 

submitted to the OMB for existing ICRs 

receive a month-to-month extension 

while they undergo review. 

Overview of This Information 

Collection 

1. Type of Information Collection: 

Extension of a previously approved 

collection. 

2. Title of the Form/Collection: Law 

Enforcement Congressional Badge of 

Bravery (CBOB). 

3. Agency form number, if any, and 

the applicable component of the 

Department of Justice sponsoring the 

collection: No form number. Sponsor: 

Office of Justice Programs, Bureau of 

Justice Assistance (BJA). 

4. Affected public who will be asked 

or required to respond, as well as a brief 

abstract: Affected Public: Federal 

Government, and State. Local and Tribal 

Governments. 

Abstract: BJA will use the CBOB 

nomination information to confirm the 

eligibility of nominees to be considered 

for the CBOB, and forward all eligible 

nominations as appropriate, to the 

Federal or the State and Local CBOB 

Board for their further consideration. In 

General—the agency heads of Federal/ 

State and Local law enforcement 

agencies many nominate for a Federal/ 

State and Local Law Enforcement 

CBOB, an individual—(1) who is a 

Federal/State and Local law 

enforcement officer working within the 

agency of the Federal/State and Local 

agency head making the nomination; 

and (2) who—(A)(i) sustained a physical 

injury while—(I) engaged in the lawful 

duties of the individual; and (II) 

performing an act characterized as 

bravery by the Federal/State and Local 

agency head making the nomination; 

and (ii) put the individual at personal 

risk when the injury described in clause 

(i) occurred; or (B) while not injured, 

performed and act characterized as 

bravery by the Federal/State and Local 

agency head making the nomination 

that placed the individual at risk of 

serious physical injury or death. BJA 

has been authorized to administer the 

CBOB Program. 

5. Obligation to Respond: Voluntary. 

6. Total Estimated Number of 

Respondents: 164. 

7. Estimated Time per Respondent: 15 

minutes. 

8. Frequency: Annually. 

9. Total Estimated Annual Time 

Burden: 41 hours. 

10. Total Estimated Annual Other 

Costs Burden: $0. 

If additional information is required, 

contact: Darwin Arceo, Department 

Clearance Officer, Policy and Planning 

Staff, Justice Management Division, 

United States Department of Justice, 

Two Constitution Square, 145 N Street 

NE, 4W–218 Washington, DC 20530. 

Dated: November 17, 2023. 

Darwin Arceo, 

Department Clearance Officer for PRA, U.S. 

Department of Justice. 

[FR Doc. 2023–25917 Filed 11–22–23; 8:45 am] 

BILLING CODE 4410–18–P 

DEPARTMENT OF JUSTICE 

Notice of Lodging of Proposed 

Consent Decree Under the Clean Air 

Act 

On November 20, 2023, the 

Department of Justice lodged a proposed 

Consent Decree (‘‘Decree’’) with the 

United States District Court for the 

District of Kansas in the lawsuit entitled 

United States of America and State of 

Kansas v. Coffeyville Resources Refining 

& Marketing, LLC, Civil Action No. 

6:04–cv–01064. 

The proposed Decree will resolve 

violations of the Clean Air Act arising 

from Coffeyville Resources Refining & 

Marketing, LLC’s (‘‘CRRM’’) operation of 

a petroleum refinery in Coffeyville, 

Kansas alleged in a supplemental 

complaint filed by Plaintiffs in 2020 and 

amended in 2023. The Decree also 

resolves Plaintiffs’ demand for 

stipulated penalties under a 2012 

consent decree. The Decree requires 

CRRM to undertake various measures to 

facilitate future compliance with the 

Clean Air Act, reduce nitrogen oxide 

emissions from the refinery’s heaters, 

and build a flare gas recovery system to 

reduce the refinery’s emissions from 

refinery flares. CRRM will pay $7 

million in stipulated penalties and 

$6.25 million in civil penalties in total 

to the United States and the State of 

Kansas, as well as spend at least $1 

million on an environmentally 

beneficial project to be approved by the 

State of Kansas. 

The publication of this notice opens 

a period for public comment on the 

Decree. Comments should be addressed 

to the Assistant Attorney General, 

Environment and Natural Resources 

Division, and should refer to United 

States et al. v. Coffeyville Resources 

Refining & Marketing, LLC, D.J. Ref. No. 

90–5–2–1–07459/5. All comments must 

be submitted no later than thirty (30) 

days after the publication date of this 

notice. Comments may be submitted 

either by email or by mail: 

To submit 

comments: Send them to: 

By email ....... pubcomment-ees.enrd@

usdoj.gov. 

By mail ......... Assistant Attorney General, 

U.S. DOJ—ENRD, P.O. 

Box 7611, Washington, DC 

20044–7611. 

During the public comment period, 

the Decree may be examined and 

downloaded at this Justice Department 

website: https://www.justice.gov/enrd/ 

consent-decrees. We will provide a 

paper copy of the Decree upon written 


ddrumheller on DSK120RN23PROD with NOTICES1